Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity

Molecules and Cells

Volumn 36, Issue 5, 2013, Pages 455-464

  Han, Jihye ^a   Rho, Seung Bae ^b   Lee, Jae Yeon ^a   Bae, Joonbeom ^a   Park, Se Ho ^a   Lee, Suk Jun ^c   Lee, Sang Yeol ^d   Ahn, Curie ^e   Kim, Jae Young ^d   Chun, Taehoon ^a  

^a Korea University   (South Korea)

^b National Cancer Center   (South Korea)

^c Gimcheon University   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Antigen presentation; HCMV US2 protein; Human CD1d; Human cytomegalovirus; Invariant NKT cell

Indexed keywords

CD1D ANTIGEN; GLYCOLIPID; MEMBRANE PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; US2 PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NATURAL KILLER T CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; VIRUS IMMUNITY;

HUMAN HERPESVIRUS 5;

ANTIGEN PRESENTATION; ANTIGENS, CD1D; CELL LINE; CYTOMEGALOVIRUS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HUMANS; IMMUNE EVASION; JURKAT CELLS; NATURAL KILLER T-CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STABILITY; UBIQUITIN; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 84900416780     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0221-8     Document Type: Article

References (43)

1. 2-microglobulin- independent MHC class Ib molecule expressed by human intestinal epithelium. Science 265, 259-262.
2. Bendelac, A., Savage, P.B., and Teyton, L. (2007). The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336. (Pubitemid 46697911)
3. Chackerian, A., Alt, J., Perera, V., and Behar, S.M. (2002). Activation of NKT cells protects Mice from tuberculosis. Infect. Immun. 70, 6302-6309. (Pubitemid 35192722)
4. Chevalier, M.S., Daniels, G.M., and Johnson, D.C. (2002). Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J. Virol. 76, 8265-8275. (Pubitemid 34809081)
5. Cho, S., and Jun, Y. (2011). Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation. Biochem. Biophys. Res. Commun. 413, 616-622.
6. Cho, S., and Hwang, E.S. (2012). Status of mTOR activity may phenotypically differentiate senescence and quiescence. Mol. Cells 33, 597-604.
7. Cohen, N.R., Garg, S., and Brenner, M.B. (2009). Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1-94.
8. De Santo, C., Salio, M., Masri, S.H., Lee, L.Y., Dong, T., Speak, A.O., Porubsky, S., Booth, S., Veerapen, N., Besra, G.S., et al. (2008). Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036-4048.
9. Dougan, S.K., Salas, A., Rava, P., Agyemang, A., Kaser, A., Morrison, J., Khurana, A., Kronenberg, M., Johnson, C., Exley, M., et al. (2005). Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202, 529-539. (Pubitemid 41186951)
10. Furman, M.H., Ploegh, H.L., and Schust, D.J. (2000). Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? Hum. Immunol. 61, 1169-1176. (Pubitemid 32043895)
11. Gewurz, B.E., Gaudet, R., Tortorella, D., Wang, E.W., Ploegh, H.L., and Wiley, D.C. (2001). Antigen presentation subverted: structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc. Natl. Acad. Sci. USA 98, 6794-6799. (Pubitemid 32538296)
12. Gewurz, B.E., Ploegh, H.L., and Tortorella, D. (2002). US2, a human cytomegalovirus-encoded type I membrane protein, contrains a non-cleavable amino-terminal signal peptide. J. Biol. Chem. 277, 11306-11313. (Pubitemid 34952895)
13. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., Van Kaer, L., Koezuka, Y., et al. (2000). alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97, 8461-8466. (Pubitemid 30639695)
14. Grubor-Bauk, B., Simmons, A., Mayrhofer, G., and Speck, P.G. (2003). Impared clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J. Immunol. 170, 1430-1434. (Pubitemid 36139511)
15. Hansen, T.H., Huang, S., Arnold, P.L., and Fermont, D.H. (2007). Patterns of nonclassical MHC antigen presentation. Nat. Immunol. 8, 563-568. (Pubitemid 46785119)
16. Ilyinskii, P.O., Wang, R., Balk, S.P., and Exley, M.A. (2006). CD1d mediates T-cell-Dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. J. Virol. 80, 7146-7158. (Pubitemid 44025211)
17. Jayawardena-Wolf, J., Benlagha, K., Chiu, Y.H., Mehr, R., and Bendelac, A. (2001). CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15, 897-908. (Pubitemid 34075371)
18. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294-4303.
19. Kakimi, K., Guidotti, L.G., Koezuka, Y., and Chisari, F.V. (2000). Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930.
20. Kang, S.J., and Cresswell, P. (2002). Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 277, 44838-44844.
21. Kawana, K., Quayle, A.J., Ficarra, M., Ibana, J.A., Shen, L., Kawana, Y., Yang, H., Marrero, L., Yavagal, S., Greene, S.J., et al. (2007). CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J. Biol. Chem. 282, 7368-7375. (Pubitemid 47093705)
22. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997). CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626-1629. (Pubitemid 27516282)
23. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998). Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA 95, 5690-5693. (Pubitemid 28224157)
24. Kim, H.S., Garcia, J., Exley, M., Johnson, K.W., Balk, S.P., and Blumberg, R.S. (1999). Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J. Biol. Chem. 274, 9289-9295.
25. Kim, E.M., Lee, H.H., Kim, S.H., Son, Y.O., Lee, S.J., Han, J., Bae, J., Kim, S.J., Park, C.G., Park, Y., et al. (2011). The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus. Mol. Immunol. 48, 2189-2197.
26. Körner, H., and Burgert, H.G. (1994). Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J. Virol. 68, 1442-1448. (Pubitemid 24065707)
27. Lee, J.H., Rho, S.B., Park, S.Y., and Chun, T. (2008). Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22. FEBS Lett. 582, 1210-1218.
28. Lin, Y., Roberts, T.J., Spence, P.M., and Brutkiewicz, R.R. (2005). Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J. Leukoc. Biol. 77, 151-158. (Pubitemid 40315048)
29. Moody, D.B., Zajonc, D.M., and Wilson, I.A. (2005). Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 5, 387-399. (Pubitemid 40685988)
30. Park, S.H., Roark, J.H., and Bendelac, A. (1998). Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160, 3128-3134. (Pubitemid 28164700)
31. + T cells, lessons from cytomegalovirus. Viral Immunol. 18, 434-444.
32. Ploegh, H.L. (1998). Viral strategies of immune evasion. Science 280, 249-253.
33. Raftery, M.J., Hitzler, M., Winau, F., Giese, T., Plachter, B., Kaufmann, S.H., and Schonrich, G. (2008). Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 82, 4308-4319. (Pubitemid 351563668)
34. Rodgers, J.R., and Cook, R.G. (2005). MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5, 459-471. (Pubitemid 40835034)
35. Sanchez, D.J., Gumperz, J.E., and Ganem, D. (2005). Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115, 1369-1378. (Pubitemid 40629057)
36. Schust, D.J., Tortorella, D., Seebach, J., Phan, C., and Ploegh, H.L. (1998). Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188, 497-503. (Pubitemid 28369139)
37. Seriger, B., Ritz, U., and Ferrone, S. (2006). Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int. J. Cancer 118, 129-138. (Pubitemid 41681589)
38. Storkus, W.J., Howell, D.N., Salter, R.D., Dawson, J.R., and Cresswell, P. (1987). NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138, 1657-1659. (Pubitemid 17040782)
39. Tomazin, R., Boname, J., Hegde, N.R., Lewinsohn, D.M., Altschuler, Y., Jones, T.R., Cresswell, P., Nelson, J.A., Riddell, S.R., and Johnson, D.C. (1999). Cytomegalovirus US2 destroys two components of the MHC class II pathways, preventing recognition by CD4+ T cells. Nat. Med. 5, 1039-1043. (Pubitemid 29439575)
40. van Dommelen, S.L., Tabarias, H.A., Smyth, M.J., and Degli-Esposti, M.A. (2003). Activation of NKT cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77, 1877-1894.
41. Wang, B., Geng, Y.B., and Wang, C.R. (2001). CD1-restricted NKT cells protect nonobese Diabetic mice from developing diabetes. J. Exp. Med. 194, 313-320.
42. Wiertz, E.J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T.R., Rapoport, T.A., and Ploegh, H.L. (1996). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384, 432-438. (Pubitemid 26414653)
43. Yang, J.Q., Chun, T., Liu, H., Hong, S., Bui, H., Van Kaer, L., Wang, C.R., and Singh, R.R. (2004). CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice. Eur. J. Immunol. 34, 1723-1732. (Pubitemid 39256055)